Molecular Partners and Orano Med formed a strategic partnership to co-develop the MP0726 candidate.
1 report, 0 independent
Updated Jun 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Molecular Partners and Orano Med formed a strategic partnership to co-develop the MP0726 candidate.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Molecular Partners
biopharmaceutical company based in Zürich, Switzerland
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet